Cargando…
Intravitreal Diclofenac for Refractory Uveitic Cystoid Macular Edema
PURPOSE: To evaluate the effect of a single dose of intravitreal diclofenac on best- corrected visual acuity (BCVA) and central macular thickness (CMT) in patients with refractory uveitic cystoid macular edema (CME). METHODS: In this prospective non-comparative case series, 8 eyes of 8 patients with...
Autores principales: | Ramezani, Alireza, Fard Esmaeilpour, Nassim, Eskandari, Armen, Rabbanikhah, Zahra, Soheilian, Roham, Soheilian, Masoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ophthalmic Research Center
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691974/ https://www.ncbi.nlm.nih.gov/pubmed/23825712 |
Ejemplares similares
-
Intravitreal therapeutic agents in noninfectious uveitic macular edema
por: Shah, Kunal Kaushik, et al.
Publicado: (2018) -
Quantitative effect of subretinal fluid and intraretinal edema on visual acuity in uveitic cystoid macular edema
por: Weldy, Eric W., et al.
Publicado: (2021) -
Spectral domain optical coherence tomography changes following intravitreal dexamethasone implant, Ozurdex(®) in patients with uveitic cystoid macular edema
por: Bansal, Pooja, et al.
Publicado: (2015) -
Repeat Intravitreal Dexamethasone Implant for Refractory Cystoid Macular Edema in Syphilitic Uveitis
por: Lautredou, Cassandra C., et al.
Publicado: (2018) -
The Effects of Intravitreal Bevacizumab in Infectious and Noninfectious Uveitic Macular Edema
por: Al-Dhibi, Hassan, et al.
Publicado: (2014)